Acute Leukemia Panel Test
Test Name: Acute Leukemia Panel Test
Components: EDTA Vacutainer (2ml)/Sodium heparin
Price: 2800.0 AED
Sample Condition: Bone Marrow / Peripheral blood
Report Delivery: 1-2 days
Method: Flowcytometry
Test type: Genetics
Doctor: General Surgeon
Test Department:
Pre Test Information
Acute Leukemia Panel can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
The Acute Leukemia Panel is a diagnostic test used to determine the specific type of acute leukemia a patient may have. It typically includes a combination of laboratory tests and genetic analysis.
The panel may include the following tests:
- Complete blood count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in the blood. Abnormal counts can indicate leukemia.
- Blood smear: A sample of blood is examined under a microscope to look for abnormal cells, such as blast cells, which are immature white blood cells often seen in leukemia.
- Bone marrow aspiration and biopsy: A small sample of bone marrow is taken and examined under a microscope to determine the percentage of blast cells present. This helps to confirm the diagnosis of leukemia.
- Flow cytometry: This test uses fluorescently-labeled antibodies to identify specific proteins on the surface of cells. It helps determine the type of leukemia by analyzing the markers present on the blast cells.
- Cytogenetic analysis: This test examines the chromosomes of the leukemia cells to identify any specific genetic abnormalities, such as translocations or deletions. These abnormalities can help guide treatment decisions and provide prognostic information.
- Molecular genetic testing: This test looks for specific genetic mutations or rearrangements in the leukemia cells. Examples include testing for mutations in genes like FLT3, NPM1, or DNMT3A. These mutations can also guide treatment decisions and provide prognostic information.
The results of the Acute Leukemia Panel help doctors determine the specific subtype of acute leukemia a patient has, which is important for determining the most appropriate treatment plan.
Test Name | Acute Leukemia Panel Test |
---|---|
Components | EDTA Vacutainer (2ml)/Sodium heparin |
Price | 2800.0 AED |
Sample Condition | Bone Marrow \/ Peripheral blood |
Report Delivery | 1-2 days |
Method | Flowcytometry |
Test type | Genetics |
Doctor | General Surgeon |
Test Department: | |
Pre Test Information | Acute Leukemia Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details | The Acute Leukemia Panel is a diagnostic test used to determine the specific type of acute leukemia a patient may have. It typically includes a combination of laboratory tests and genetic analysis. The panel may include the following tests: 1. Complete blood count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in the blood. Abnormal counts can indicate leukemia. 2. Blood smear: A sample of blood is examined under a microscope to look for abnormal cells, such as blast cells, which are immature white blood cells often seen in leukemia. 3. Bone marrow aspiration and biopsy: A small sample of bone marrow is taken and examined under a microscope to determine the percentage of blast cells present. This helps to confirm the diagnosis of leukemia. 4. Flow cytometry: This test uses fluorescently-labeled antibodies to identify specific proteins on the surface of cells. It helps determine the type of leukemia by analyzing the markers present on the blast cells. 5. Cytogenetic analysis: This test examines the chromosomes of the leukemia cells to identify any specific genetic abnormalities, such as translocations or deletions. These abnormalities can help guide treatment decisions and provide prognostic information. 6. Molecular genetic testing: This test looks for specific genetic mutations or rearrangements in the leukemia cells. Examples include testing for mutations in genes like FLT3, NPM1, or DNMT3A. These mutations can also guide treatment decisions and provide prognostic information. The results of the Acute Leukemia Panel help doctors determine the specific subtype of acute leukemia a patient has, which is important for determining the most appropriate treatment plan. |